Sun Pharmaceutical Industries Limited Financial Overview
Sun Pharmaceutical Industries Limited's market cap is currently ₹4.31T. The company's EPS TTM is ₹13; its P/E ratio is 41.20; and it has a dividend yield of 0.89%. Sun Pharmaceutical Industries Limited is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is ₹12.77. See an overview of income statement, balance sheet, and cash flow financials.
